Literature DB >> 23865893

Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome.

Marlies Wallner1, Andrew C Bulmer, Christine Mölzer, Elisabeth Müllner, Rodrig Marculescu, Daniel Doberer, Michael Wolzt, Oswald F Wagner, Karl-Heinz Wagner.   

Abstract

BACKGROUND: Moderately elevated unconjugated bilirubin concentrations protect against inflammatory diseases and are present in individuals with Gilbert's syndrome. This study examined the relationship between circulating haem oxygenase catabolites, unconjugated bilirubin, carboxy haemoglobin, iron and inflammatory parameters.
MATERIALS AND METHODS: Seventy-six matched individuals were allocated to Gilbert's syndrome (GS) or control group (unconjugated bilirubin ≥ or < 17.1 μM). Iron, carboxy haemoglobin and high-sensitivity C-reactive protein were analysed using routine diagnostic tests. Unconjugated bilirubin and haem were analysed using high-performance liquid chromatography. The cytokines IL-1β, TNF-α and IL-6 were assessed using high-sensitivity enzyme-linked immunosorbent assays.
RESULTS: Gilbert's syndrome subjects had significantly greater levels of unconjugated bilirubin (P < 0.05), carboxy haemoglobin (P < 0.05), iron (P < 0.05), IL-1β (P < 0.05), a significantly lower body mass index (P < 0.05) and IL-6 concentrations (P < 0.05) vs. controls. Regression analysis revealed that unconjugated bilirubin mainly explained IL-1β results (16%), and body mass index+IL-6 predicted 26% of the variance in C-reactive protein concentrations.
CONCLUSIONS: A positive relationship between unconjugated bilirubin and free plasma haem, iron and carboxy haemoglobin indicated a positive feedback loop of haem oxygenase induction possibly mediated by unconjugated bilirubin. Furthermore, reduced body mass index in Gilbert's syndrome individuals was linked to reduced inflammation status, which could be influenced by circulating haem oxygenase catabolites and contribute to reduced risk of noncommunicable diseases in this population.
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cytokines; Gilbert's syndrome; haem oxygenase; metabolic syndrome; obesity; unconjugated bilirubin

Mesh:

Substances:

Year:  2013        PMID: 23865893     DOI: 10.1111/eci.12120

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

Review 1.  Heme oxygenase-1: a metabolic nike.

Authors:  Barbara Wegiel; Zsuzsanna Nemeth; Matheus Correa-Costa; Andrew C Bulmer; Leo E Otterbein
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

Review 2.  Bilirubin and Ischemic Stroke: Rendering the Current Paradigm to Better Understand the Protective Effects of Bilirubin.

Authors:  Mrugesh Thakkar; Jurian Edelenbos; Sylvain Doré
Journal:  Mol Neurobiol       Date:  2019-01-05       Impact factor: 5.682

3.  Potential cardiovascular risk protection of bilirubin in end-stage renal disease patients under hemodialysis.

Authors:  Maria do Sameiro-Faria; Michaela Kohlova; Sandra Ribeiro; Petronila Rocha-Pereira; Laetitia Teixeira; Henrique Nascimento; Flávio Reis; Vasco Miranda; Elsa Bronze-da-Rocha; Alexandre Quintanilha; Luís Belo; Elísio Costa; Alice Santos-Silva
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

4.  Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels.

Authors:  Jinfeng Liu; Huansheng Dong; Yong Zhang; Mingjun Cao; Lili Song; Qingjie Pan; Andrew Bulmer; David B Adams; Xiao Dong; Hongjun Wang
Journal:  Sci Rep       Date:  2015-05-28       Impact factor: 4.379

5.  Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's Syndrome.

Authors:  Anela Tosevska; Christine Moelzer; Marlies Wallner; Milan Janosec; Ursula Schwarz; Carina Kern; Rodrig Marculescu; Daniel Doberer; Wolfram Weckwerth; Karl-Heinz Wagner
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

6.  Characteristics of the heme catabolic pathway in mild unconjugated hyperbilirubinemia and their associations with inflammation and disease prevention.

Authors:  Christine Mölzer; Marlies Wallner; Carina Kern; Anela Tosevska; René Zadnikar; Daniel Doberer; Rodrig Marculescu; Karl-Heinz Wagner
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

7.  Endogenous Tetrapyrroles Influence Leukocyte Responses to Lipopolysaccharide in Human Blood: Pre-Clinical Evidence Demonstrating the Anti-Inflammatory Potential of Biliverdin.

Authors:  Kavita Bisht; Jens Tampe; Cecilia Shing; Bhavisha Bakrania; James Winearls; John Fraser; Karl-Heinz Wagner; Andrew C Bulmer
Journal:  J Clin Cell Immunol       Date:  2014-05-30

8.  Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling.

Authors:  Kavita Bisht; Barbara Wegiel; Jens Tampe; Oliver Neubauer; Karl-Heinz Wagner; Leo E Otterbein; Andrew C Bulmer
Journal:  Biochem Biophys Res Commun       Date:  2014-05-09       Impact factor: 3.575

9.  Features of an altered AMPK metabolic pathway in Gilbert's Syndrome, and its role in metabolic health.

Authors:  Christine Mölzer; Marlies Wallner; Carina Kern; Anela Tosevska; Ursula Schwarz; Rene Zadnikar; Daniel Doberer; Rodrig Marculescu; Karl-Heinz Wagner
Journal:  Sci Rep       Date:  2016-07-21       Impact factor: 4.379

10.  Relation between unconjugated bilirubin and RDW, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio in Gilbert's syndrome.

Authors:  Hakan Sarlak; Erol Arslan; Mustafa Cakar; Mustafa Tanriseven; Salim Ozenc; Muharrem Akhan; Fatih Bulucu
Journal:  Springerplus       Date:  2016-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.